// App-Quantinova.ai

GS2-03 : The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer

Researchers

Presenter

  • Elgene Lim

Principal Investigators

  • Luke A Selth

  • Kee Ming Chia

  • Heloisa H Milioli

  • Daniel Roden

  • Geraldine Laven-Law

  • Shalini Jindal

  • Mun Hui

  • Esmaeil Ebrahimie

  • Stephen N Birrell

  • Suzan Stelloo

  • C. Elizabeth Caldon

  • Jessica Finlay-Schultz

  • Tarek M Abdel-Fatah

  • Ian O Ellis

  • Willbert Zwart

  • Carlo Palmieri

  • Carol A Sartorius

  • Alex Swarbrick

  • Jason S Carroll

  • Wayne D Tilley

Medical Centers

  • The Garvan Institute of Medical Research, University of New South Wales, Sydney, Australia

  • Dame Roma Mitchell Cancer Research Laboratory, University of Adelaide, Adelaide, Australia

  • Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands

  • University of Colorado Cancer Center, Aurora, CO

  • University of Liverpool, Liverpool, United Kingdom

  • Cancer Research UK Cambridge Institute, University of Cambridge., Cambridge, United Kingdom

Locations

  • Australia

  • Netherlands

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Androgen receptor

  • Cyclin-dependent kinase 4

  • E1A Binding Protein P300

  • Estrogen Receptor 1

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved